Avantec Vascular Corporation – FDA 483, Jan 10, 2020
Avantec Vascular Corporation in Sunnyvale, CA, a medical device manufacturer, received a Form 483 with three observations during an FDA inspection. The firm was cited for inadequate documentation of corrective and preventive actions for nonconforming material, failure to revalidate a manufacturing process after changes, and an insufficient risk analysis for its Captus Vascular Retrieval System. These findings indicate deficiencies in the company's quality system regarding CAPA, process control, and design control.
ID · 68310006-fdf8-4a98-bfd0-de4822932aef
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.